FEB 03, 2021 8:08 AM PST

New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy

WRITTEN BY: Tara Fernandez

Rheumatoid arthritis, or RA, is a painful and debilitating autoimmune disorder of the joints, particularly those of the wrists and hands. The disease can also affect other parts of the body, causing inflammation of vital organs and anemia. As of 2015, 24.5 million people are estimated to be living with RA.

A study published in Arthritis Research & Therapy has detailed the development of a panel of four RA biomarkers, improving the accuracy and reliability of RA diagnoses, of which false negatives are an ongoing issue.

This panel of four includes measurements of angiotensinogen (AGT), serum amyloid A-4 protein (SAA4), vitamin D-binding protein (VDBP), and retinol-binding protein-4 (RBP4). These were determined through an in-depth analysis of samples from a cohort of over 250 RA patients alongside 230 healthy individuals.

Conventional diagnostic biomarkers, immunoglobin M and anti-CCP aren’t the most reliable for detecting RA, particularly at the early stages. “Existing biomarkers have limitations concerning RA diagnosis. For example, the sensitivity and specificity of RF are 60-90% and 85%, respectively,” wrote the authors. 

“To improve the efficiency of RA diagnosis, anti-CCP is used with RF. Anti-CCP has higher ACCP positivity than RF positivity among RA patients; however, the sensitivity and specificity of the 2 markers do not significantly differ.”

The newly-identified panel of four biomarkers performs significantly better, say the authors. “Together, the 4-biomarker panel accurately classified 234 healthy controls and 210 RA patients with a classification accuracy of 93.2% and 91.7% for healthy controls and RA patients, respectively.”

Though there is no cure for the disease and no known prevention other than a reduction of risk factors where possible, an early diagnosis is critical in managing the disease. The hope is that evolving clinical practices to detect and monitor RA more effectively will improve the quality of life for these patients.

 



Source: Arthritis Research & Therapy.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
FEB 02, 2021
Clinical & Molecular DX
Keeping an Eye on COVID Clusters With Rapid Sequencing
FEB 02, 2021
Keeping an Eye on COVID Clusters With Rapid Sequencing
Contact tracing is a powerful tool used by public health authorities to help slow the spread of infectious diseases such ...
FEB 03, 2021
Immunology
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
FEB 03, 2021
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
Researchers are still studying how long a person can stay immune against COVID-19 following infection. A new study by a ...
MAR 11, 2021
Clinical & Molecular DX
Racial Disparities in ADHD Diagnoses
MAR 11, 2021
Racial Disparities in ADHD Diagnoses
Researchers have found significant racial disparities in ADHD diagnoses and treatment: Black, Hispanic, and Asian childr ...
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
APR 20, 2021
Cardiology
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
APR 20, 2021
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
Diabetes is a looming threat to the world’s healthcare systems. Diagnoses of its precursors, impaired glucose tole ...
MAY 04, 2021
Cardiology
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
MAY 04, 2021
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
Sleep is a time for your body to rest and recover from the day. Your heart slows down, and your breathing relaxes.   ...
Loading Comments...